Search Results - "Poyck, P.P.C."

Is biliopancreatic diversion with duodenal switch a solution for patients after laparoscopic gastric banding failure? by Poyck, P.P.C., M.D., Ph.D, Polat, F., M.D, Gouma, D.J., M.D., Ph.D, Hesp, W.L.E.M., M.D., Ph.D

“…Abstract Background Weight loss failure after laparoscopic gastric banding (LAGB) can occur in ≤25% of patients. Conversion to a malabsorptive procedure might…”
Get full text

Extra‐hepatic factor VIII expression in porcine fulminant hepatic failure by HOLLESTELLE, M. J., POYCK, P. P. C., HOLLESTELLE, J. M., MARSMAN, H. A., MOURIK, J. A., GULIK, T. M.

“…In humans, fulminant hepatic failure (FHF) is frequently associated with increased factor VIII (FVIII) levels, despite widespread liver cell death. The…”
Get full text

Liver support therapy: an overview of the AMC-bioartificial liver research by van de Kerkhove, M P, Poyck, P P C, Deurholt, T, Hoekstra, R, Chamuleau, R A F M, van Gulik, T M

“…Acute liver failure (ALF) is a disease with a mortality of 60-90% depending on the cause. Only high-urgency liver transplantation is able to increase survival…”
Get more information

A novel role for local immune suppression in chronic q fever infected abdominal aortic aneurysms? by Staal, A.H.J, Cortenbach, K.R.G, Wever, P.C, Van Suylen, R.J, Poyck, P.P.C, Srinivas, M, Van Deuren, M, Bleeker-Rovers, M.C, Van Der Meer, J.W.M, De Vries, I.J.M, Van Kimmenade, R.R.J

“…Abstract Background Chronic Q fever (QCF) is the persistence of C. Burnettii after an acute infection. Atheromas in the abdominal aorta are a preferential…”
Get full text

Randomised Clinical Trial of Supervised Exercise Therapy vs Endovascular Revascularisation for Intermittent Claudication Caused by Iliac Artery Obstruction: The SUPER study by Koelemay, M.J.W., van Reijen, N.S., van Dieren, S., Frans, F.A., Vermeulen, E.J.G., Buscher, H.C.J.L., Reekers, J.A., Dijkgraaf, M.G.W., de Haan, R.J., Balm, R., Idu, M.M., Blankensteijn, J.D., Hoksbergen, A.W., Conijn, A.P., Met, R., Legemate, D.A., Bipat, S., van Lienden, K.P., van Delden, O.M., Zijlstra, E.J., Lely, R., Engelbert, R.H.H., van Egmond, M.A., Poelgeest, A., Geleijn, E., de Nie, A.J., Schreve, M.A., Kamphuis, A., Kropman, R.H.J., Wille, J., de Vries, J.P.M.M., van de Mortel, R.H., van de Pavoord, H.D., van den Heuvel, D.A., van Leersum, M., van Strijen, M.J., Vos, J.A., Nio, D., Rijbroek, A., Akkersdijk, G.J.M., Metz, R., van Kelckhoven, B.J., van de Rest, H.J., Leijdekkers, V.J., Vahl, A.C., van Nieuwenhuizen, R.C., Blomjous, J.G., Montauban van Swijndregt, A.D., Poyck, P.P.C., van der Jagt, M., van der Vliet, J.A., Schultze Kool, L.J., Klemm, P.L., Slis, H.W., Willems, M.C.M., Huisman, L.C., de Bruine, J.H.D., Mallant, M.J., Smeets, L., van Sterkenburg, S.M., Reijnen, M.M., Veendrick, P.B., van Werkum, M.H., van Ostayen, J.A., Elsman, B.H.P., van der Hem, L.G., van Tongeren, R.B.M., Klok, C.F.M., Hellings, W.E., Aarts, J.C., Wiersema, A.M., van den Broek, T.A., Moolhuijzen, A., Teijink, J.A., van Sambeek, M.R., Keller, B.P., Vos, G.A., Breek†, J.C., Gravendeel, J., Oosterhof-Berktas, R., Koedam, N.A., Hollander, E.J., Pels Rijcken, T., van der Voort, S.S., Honing, B., Scharn, D.M., Lemson, M.S., Seegers, J., Krol, R.M.

Get full text

Numerical modeling of oxygen availability in the AMC bioartificial liver by Mareels, G., Poyck, P.P.C., Eloot, S., Chamuleau, R.A.F.M., Verdonck, P.R.

Get full text

Outcome of 232 morbidly obese patients treated with laparoscopic adjustable gastric banding between 1995-2003 by Polat, F, Poyck, P P C, Dickhoff, C, Gouma, D J, Hesp, W L E M

“…Laparoscopic adjustable gastric banding (LAGB) is widely used for the treatment of morbidly obese patients. We prospectively evaluated the effect of LAGB since…”
Get more information

In vitro comparison of two bioartificial liver support systems: MELS CellModule and AMC-BAL by Poyck, P P C, Pless, G, Hoekstra, R, Roth, S, Van Wijk, A C W A, Schwartländer, R, Van Gulik, T M, Sauer, I M, Chamuleau, R A F M

“…Clinically applied bioartificial liver (BAL) support systems are difficult to compare with regard to overall hepatocyte-specific function and clinical outcome…”
Get full text

Assessment and improvement of liver specific function of the AMC-bioartificial liver by van de Kerkhove, M P, Poyck, P P C, van Wijk, A C W A, Galavotti, D, Hoekstra, R, van Gulik, T M, Chamuleau, R A F M

“…The variety of methods for measuring bioactive mass and functionality of bioartificial livers (BAL) is confusing and prevents accurate comparison of reported…”
Get full text